Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic

Bibliographic Details
Main Authors:	Zarir F Udwadia, Samridhi Sharma, Jai B Mullerpattan, Ishita Gajjar, Lancelot Pinto
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Lung India
Online Access:	http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=1;spage=98;epage=99;aulast=Udwadia

Similar Items

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
by: Zarir F Udwadia, et al.
Published: (2016-01-01)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
by: Roma Haresh Paryani, et al.
Published: (2020-05-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Bedaquiline in the treatment of extensively drugresistant tuberculosis
by: T. I. Morozova, et al.
Published: (2022-04-01)

Why "covering all" in the DOTS program is not necessarily "all being covered" by the DOTS program
by: Pinto Lancelot, et al.
Published: (2010-01-01)

EXTENSIVELY DRUG RESISTANT TUBERCULOSIS (XDR TB)
by: Sarah Rahmayani Siregar
Published: (2019-12-01)

XDR-TB, extensively drug-resistant tuberculosis
by: Ernesto Jaramillo
Published: (2007-12-01)

Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China
by: Shao-Jun Zhang, et al.
Published: (2022-08-01)

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
by: Zarir F Udwadia, et al.
Published: (2015-01-01)

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
by: Thi Mai Phuong Nguyen, et al.
Published: (2022-10-01)

Results of treatment with bedaquiline containing regimens of MDR/XDR tuberculosis patients including those with concurrent HIV infection (the experience of Leningrad Region)
by: T. I. Danilova, et al.
Published: (2020-10-01)

XDR tuberculosis: A looming threat
by: Sharma Vishal, et al.
Published: (2009-01-01)

Who will teach the teachers: An analysis of the inhaler technique of Indian patients and health care providers in a tertiary health care centre
by: Jai Bharat Mullerpattan, et al.
Published: (2016-01-01)

Totally drug resistant-tuberculosis in India: The bad just got worse
by: Zarir F Udwadia
Published: (2016-01-01)

Eﬃcacy of using bedaquiline in treatment of tuberculosis patients with multiple and extensive drug resistance
by: A. A. Starshinova, et al.
Published: (2022-06-01)

Quality of drug-resistant tuberculosis care: Gaps and solutions
by: Zarir Udwadia, et al.
Published: (2019-08-01)

Extensively Drug-resistant Tuberculosis (XDR-TB) Raises Challenges in TB Control in Taiwan
by: Wei-Juin Su
Published: (2008-11-01)

First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait
by: Eiman Mokaddas, et al.
Published: (2021-11-01)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
by: Jai B Mullerpattan, et al.
Published: (2019-01-01)

Disseminated tuberculosis with immune thrombocytopenic purpura
by: Rucha S Dagaonkar, et al.
Published: (2012-01-01)

Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
by: Francesco Pecora, et al.
Published: (2021-05-01)

Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
by: Koen Andries, et al.
Published: (2014-01-01)

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
by: Juan Eduardo Resendiz-Galvan, et al.
Published: (2023-01-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
by: Zarir F. Udwadia, et al.
Published: (2019-01-01)

Transmission of MDR and XDR tuberculosis in Shanghai, China.
by: Ming Zhao, et al.
Published: (2009-01-01)

Tuberculosis in South Asia: a tide in the affairs of men
by: Buddha Basnyat, et al.
Published: (2018-03-01)

Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis.
by: Ginenus Fekadu, et al.
Published: (2022-01-01)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of <i>Mycobacterium tuberculosis</i>
by: María Alejandrina Martínez-González, et al.
Published: (2021-12-01)

Extensively drug-resistant tuberculosis treated with bedaquiline: A case report in the particularly vulnerable tribal group of Madhya Pradesh, India
by: Prashant Mishra, et al.
Published: (2021-01-01)

INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2018-03-01)

Effect of tellurite on growth of extensively drug resistant (XDR) Mycobacterium tuberculosis and action on mycobacterial drug efflux pump
by: Saba Kabir, et al.
Published: (2023-05-01)

Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.
by: Thandi Kapwata, et al.
Published: (2017-01-01)

Whole genome sequencing-based characterization of extensively drug resistant (XDR) strains of Mycobacterium tuberculosis from Pakistan
by: Zahra Hasan, et al.
Published: (2015-01-01)

Bedaquiline in the treatment regimen of multidrugresistant tuberculosis (clinical observation)
by: V. A. Aksenova, et al.
Published: (2020-11-01)